๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› China
Clinical trial register · China

Studies with a Chinese investigative site

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the register
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University490 Fudan University472 Second Affiliated Hospital, Zhejiang University, School of Medicine404 Peking Union Medical College Hospital282 Ruijin Hospital281
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to
19052 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Patients With Invasive Mold Infections.
NCT06925321Invasive Mold Infections
Basilea Pharmaceutica
Phase 3
234
2025-08-26
Recruiting
IBI363 Combined With Chemotherapy or Pembrolizumab Combined With Chemotherapy as Neoadjuvant Therapy in Resectable Stage IB-III Non-Squamous Non-Small Cell Lung Cancer
NCT07122687Resectable Stage IB-III Non-Squamous Non-Small Cell Lung Cancer
Innovent Biologics (Suzhou) Co. Ltd.
Phase 2
170
Shenyang
2025-08-26
Recruiting
Golidocitinib and Chidamide for Cutaneous T-Cell Lymphoma
NCT07754890Cutaneous T-cell Lymphoma (CTCL)
Peking Union Medical College Hospital
Phase 1/2
65
Beijing
2025-08-26
Recruiting
Real-Time Diagnosis of Eosinophilic Nasal Polyps Using High-Sensitivity Spectroscopy
NCT07125586Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
The Affiliated Hospital of Qingdao University
Not applicable
353
Qingdao
2025-08-26
Not yet open
Child Vaccination Scheduling in China
NCT07141875Vaccination Behavior
Peking University
Observational
6,000
Beijing
2025-08-25
Recruiting
Anti CD19/BCMA CAR Gene Therapy for Autoimmune Diseases
NCT07121777Autoimmune Diseases
Anhui Provincial Hospital
Not applicable
18
Hefei
2025-08-25
Recruiting
LineMatrixยฎ Biological Vascular Graft for the Creation of Arteriovenous Graft
NCT07773051Arteriovenous Graft
Longhua Hospital
Not applicable
326
Beijing, Chongqing, Shenzhen, Shijiazhuang, Zhengzhou, Wuhan, Nanjing, Nanchang
2025-08-25
Recruiting
A Phase 2 Study of Budoprutug in Subjects With Primary Membranous Nephropathy
NCT07096843Primary Membranous Nephropathy
Climb Bio, Inc.
Phase 2
45
Beijing, Shenzhen, Wuxi, Xi'an, Jinan, Yantai, Yibin
2025-08-25
Recruiting
Sequential PEG-IFN for HBV After Ending RNA-targeted Regimens
NCT06923280Hepatitis B, Chronic
Huashan Hospital
Not applicable
72
Beijing, Shanghai
2025-08-25
Recruiting
Adebrelimab Combine With Etoposide Capsules in ES-SCLC Maintenance Therapy
NCT07141264SCLC,Extensive Stage
Tang-Du Hospital
Phase 2
32
Xi'an
2025-08-25
Not yet open
Envafolimab Combined With Neoadjuvant Chemotherapy Treat Stage IIb Resectable Osteosarcoma Patients
NCT07142863Osteosarcoma, Neoadjuvant Therapy, Neoadjuvant Chemotherapy, PD-L1 Antibody
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase 2
23
Shanghai
2025-08-25
Not yet open
Intracochlear Injection of Glucocorticoid
NCT07134075Sudden Sensorineural Hearing Loss (SSNHL)
Eye & ENT Hospital of Fudan University
Phase 2
150
Shanghai
2025-08-25
Not yet open
Effect of Light-Blocking Lenses on Pediatric Hyperopia
NCT07142915Hyperopia
Zhongshan Ophthalmic Center, Sun Yat-sen University
Not applicable
156
Guangzhou
2025-08-25
Recruiting
Impact of Capsular Tension Ring on Intraocular Lens Position in Retinitis Pigmentosa Cataract Patients
NCT07126470Cataract, Retinitis Pigmentosa (RP)
Zhongshan Ophthalmic Center, Sun Yat-sen University
Not applicable
88
Guangzhou, Shenzhen, Wuhan
2025-08-25
Recruiting
CTR-FAPI-guided Precision Surgery for Newly Diagnosed MTC
NCT07383246Medullary Thyroid Carcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 3
150
Beijing
2025-08-25
Active, closed
Milk Free From A1-Type ฮฒ-Casein on Inflammation, Gastrointestinal Tolerance, and Pregnancy Outcomes
NCT06980376Healthy Pregnant Women
a2 Milk Company Ltd.
Not applicable
100
Foshan, Guangzhou, Wuxi, Xuzhou, Chengdu
2025-08-25
Recruiting
A Study of Anti-CD38 Monoclonal Antibody (SG301) Subcutaneous Injection in Children With Nephrotic Syndrome With Frequent Relapses or Steroid Dependence
NCT07087314Nephrotic Syndrome in Children
Mao Jianhua
Phase 2
30
Hangzhou
2025-08-25
Recruiting
Radiation Combined With BCMA/CD3 Bispecific Antibody Therapy for Solitary Bone Plasmacytoma With Mild Bone Marrow Infiltration
NCT07115667Solitary Bone Plasmacytoma, Plasmacytoma of Bone, Plasma Cell Disorders
Institute of Hematology & Blood Diseases Hospital, China
Phase 2
21
Tianjin
2025-08-25
Recruiting
To Evaluate the Safety, Tolerability, and Preliminary Efficacy of XH001 Injection as Adjuvant Therapy in Patients With High-risk Recurrent Solid Tumors
NCT07594964Biliary Cancer (Cholangiocarcinoma, Gall Bladder Cancer), Pancreatic Ductal Adenocarcinoma (PDAC), Hepatocellular Carcinoma (HCC), Gastric Cancer (GC)
Shenzhen Xinhe Biomedical
Phase 1
48
Beijing
2025-08-25
Recruiting
Study of YK012 in Moderate to Severe Systemic Lupus Erythematosus
NCT07010835Systemic Lupus Erythematosus (SLE)
Excyte Biopharma Ltd
Phase 1/2
189
Beijing
2025-08-25
Not yet open
Effect of Light-Blocking Lenses on Hyperopic Anisometropic Children
NCT07142928Anisometropia, Hyperopia
Zhongshan Ophthalmic Center, Sun Yat-sen University
Not applicable
90
Guangzhou
2025-08-25
Recruiting
A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of TJ101 in Patients With Advanced/Metastatic Solid Tumors
NCT07181473Lung Cancer (NSCLC), Prostate Cancer, Esophageal Cancer, Solid Tumor Malignancies
Phrontline Biopharma
Phase 1
200
Zhengzhou, Wuhan, Hangzhou, Shanghai
2025-08-25
Recruiting
HRS-4642 in Combination With Gemcitabine and Albumin-bound Paclitaxel and Adebrelimab for Neoadjuvant and Adjuvant Treatment of Pancreatic Cancer
NCT07131514Pancreatic Cancer
Ruijin Hospital
Phase 2
30
Shanghai
2025-08-25
Recruiting
Effects of Telitacicept vs Cyclophosphamide on Lupus Related Interstitial Lung Disease
NCT07077486Lupus or SLE, Interstitial Lung Disease, Systemic Lupus Erythematosus
Tongji Hospital
Phase 4
100
Wuhan
2025-08-25
Recruiting
Efficacy and Safety of Brivudine in the Treatment of Herpes Zoster
NCT07099157Herpes Zoster
Peking University Third Hospital
Phase 4
140
Beijing
2025-08-25
Recruiting
A Study to Evaluate the Long-Term Safety and Efficacy of HSK39297 Tablets in Primary IgA Nephropathy
NCT07616700IgA Nephropathy (IgAN)
Haisco Pharmaceutical Group Co., Ltd.
Phase 2
73
Beijing
2025-08-25
Recruiting
A Random Controlled Trial of Home-based Digital Therapy for Treating ADHD in Children
NCT07552909Attention Deficit Hyperactivity Disorder (ADHD)
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Not applicable
146
Shanghai
2025-08-24
Not yet open
Arrhythmia Cohort Study
NCT07123896Arrhythmia
Beijing Anzhen Hospital
Observational
10,000
Beijing
2025-08-24
Recruiting
A Study of Yttrium [90Y] Microsphere Injection in Combination With Targeted Immunotherapy in the Treatment of HCC
NCT07334483HCC
GrandPharma (China) Co., Ltd.
Phase 2
120
Beijing, Nanjin, Shanghai
2025-08-22
Recruiting
Cochlear Implant Recipients: Comprehensive Longitudinal Evaluation
NCT07380269Hearing Loss, Hearing Loss, Sensorineural, Deafness, Cochlear Implantation
Eye & ENT Hospital of Fudan University
Observational
300
Shanghai
2025-08-22
Recruiting
Phase I Study of Single/Multiple Ascending Doses of JKN2501 for Injection in Chinese Healthy Volunteers
NCT07207291Bacterial Infections, Urinary Tract Infections, Intra-Abdominal Infections, Respiratory Tract Infections
Joincare Pharmaceutical Group Industry Co., Ltd
Phase 1
66
Changsha
2025-08-22
Recruiting
GT719 Injection for Moderate to Severe Refractory Autoimmune Diseases
NCT07122076Autoimmune Diseases
Grit Biotechnology
Phase EARLY_PHASE1
10
Shanghai
2025-08-22
Recruiting
Lparomlimab and Tuvonralimab Injection in Combination With TACE and Lenvatinib in the Treatment of Second-Line Therapy for Unresectable Intermediate-to-Advanced Hepatocellular Carcinoma
NCT07099274HCC
Tianjin Medical University Cancer Institute and Hospital
Phase 2
29
Tianjin
2025-08-22
Recruiting
Clinical Cohort Construction and Therapeutic Effect Evaluation of Integrated Traditional Chinese and Western Medicine in the Treatment of Rheumatoid Arthritis
NCT07484243Rheumatoid Arthritis (RA), Rheumatoid Arthritis-Associated Interstitial Lung Disease, Difficult-to-Treat Rheumatoid Arthritis
Dongyi He
Observational
10,000
Shanghai
2025-08-22
Recruiting
To Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of KN060 in ESRD Dialysis Patients
NCT07201467End-Stage Renal Disease Requiring Haemodialysis
Suzhou Alphamab Co., Ltd.
Phase 1/2
12
Beijing
2025-08-22
Recruiting
Neoadjuvant Iparomlimab and Tuvonralimab Plus Chemotherapy-eclipse for Locally Advanced Cervical Cancer (NICE-CC)
NCT07055399Locally Advanced Cervical Cancer
Fujian Cancer Hospital
Phase 2
43
Fuzhou
2025-08-21
Recruiting
A Study of BL-B01D1 + Pembrolizumab ยฑ Bevacizumab in Patients With Recurrent or Metastatic Cervical Cancer and Endometrial Cancer
NCT07054567Cervical Cancer, Endometrial Cancer
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 2
96
Shanghai
2025-08-21
Recruiting
AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions
NCT06959524Coronary Arterial Disease (CAD), de Novo Lesions in Native Coronary Arteries
Boston Scientific Corporation
Not applicable
1,616
Beijing, Beijin, Guangzhou, Wuhan, Xi'an
2025-08-21
Recruiting
A Study of Enlicitide Decanoate (MK-0616, an Oral PCSK9 Inhibitor) in Children and Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0616-029)
NCT07058077Heterozygous Familial Hypercholesterolemia (HeFH)
Merck Sharp & Dohme LLC
Phase 2/3
153
Beijing, Guangzhou, Shanghai, Hangzhou
2025-08-21
Recruiting
A Study to Evaluate the Efficacy and Safety of ICP-248 in Subjects With Relapsed or Refractory Mantle Cell Lymphoma (APEX-06)
NCT07082686Relapsed or Refractory Mantle Cell Lymphoma (MCL)
Beijing InnoCare Pharma Tech Co., Ltd.
Phase 2
75
Hefei, Beijing, Chengdu, Chongqing, Fuzhou, Guangzhou, Nanning, Zhengzhou
2025-08-21
Recruiting
Electroacupuncture for Chemotherapy-Induced GI Symptom Clusters in Breast Cancer
NCT06952920Standard Quadruple Antiemetic Therapy, Electroacupuncture, Chemotherapy-induced Gastrointestinal Symptom Cluster
Jiuda Zhao
Phase 3
388
Xining
2025-08-21
Recruiting
Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)
NCT07154706Non-small Cell Lung Cancer (NSCLC)
Nuvation Bio Inc.
Phase 3
180
Beijing, Guangzhou, Nanning, Zhengzhou, Wuhan, Nanjing, Nantong, Nanchang
2025-08-21
Recruiting
Venetoclax-Enhanced BUCY vs. Standard BUCY Conditioning in High-Risk AML and MDS Patients Undergoing Allo-HSCT (Ven-BUCY Study)
NCT07183878Acute Myeloid Leukemia, High-Risk Acute Myeloid Leukemia, Myelodysplastic Syndromes, High-Risk Myelodysplastic Syndromes
First Affiliated Hospital of Zhejiang University
Not applicable
138
Hangzhou
2025-08-20
Recruiting
A Clinical Trial of SHR-A1811 in the Treatment of Triple-negative Breast Cancer
NCT07111832PD-L1-positive Locally Recurrent Unresectable or Metastatic Triple-negative Breast Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 3
400
Beijing, Shanghai
2025-08-20
Active, closed
The Efficacy and Safety of Neoadjuvant Therapy With Iparomlimab and Tuvonralimab in Locally Advanced MSI-H/dMMR Colorectal Cancer: An Prospective, Single-Arm Study (Neo-IT)
NCT07160647dMMR/MSI-H-type Rectal Adenocarcinoma
Sir Run Run Shaw Hospital
Phase 2
29
Hangzhou
2025-08-20
Recruiting
Phase III Non-Inferiority Trial: Reduced-Target vs. Full-Target IMRT After Chemo in Immunotherapy-Treated Metastatic Nasopharyngeal Cancer
NCT07188584Nasopharyngeal Carcinoma (NPC)
Ming-Yuan Chen
Phase 3
166
Zhuhai
2025-08-20
Recruiting
An Clinical Study Evaluating the Safety, Tolerability, and efficAcy of HG005 in StaRgardT Disease
NCT07063251Stargardt Disease Type 1 (STGD1)
HuidaGene Therapeutics Co., Ltd.
Phase EARLY_PHASE1
6
Shanghai
2025-08-20
Not yet open
Lateral Positioning for Extubation After Adenotonsillectomy
NCT07108218Perioperative Respiratory Adverse Events, Adenoidectomy, Tonsillectomy, Children
Sichuan University
Not applicable
350
Chengdu
2025-08-20
Not yet open
To Observe the Clinical Effect of Femoral Nerve Block With Low Concentration of Ropivacaine Based on DPN Grading
NCT06732362Diabetes Mellitus, Type 2
Zheng Guo
Observational
60
Taiyuan
2025-08-20
Recruiting
Nanocrystalline Megestrol Acetate in Concurrent Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer
NCT07150663Non-small Cell Lung Cancer
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 3
134
Wuhan
2025-08-20
Recruiting
Transcranial Alternating Current Stimulation for Refractory Constipation With Somatic Symptom Disorder
NCT07323407Functional Constipation (FC), Somatic Symptom Disorder (DSM-5), Refractory Constipation
Xijing Hospital of Digestive Diseases
Not applicable
60
Xi'an
2025-08-20
Recruiting
A Phase 1 MAD Study to Evaluate the Safety and Tolerability of LY03020
NCT07230652Schizophrenia, Alzheimer's Disease Psychosis
Luye Pharma Group Ltd.
Phase 1
40
Beijing
2025-08-20
Not yet open
Neoadjuvant Treatment of Locally Advanced Hypopharyngeal Cancer With Adebrelimab Combined With TP Chemotherapy Regimen
NCT07137039Locally Advanced Hypopharyngeal Cancer
The First Affiliated Hospital of Xiamen University
Phase 2
34
Xiamen
2025-08-20
Recruiting
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
NCT07090499Advanced/Metastatic Solid Tumors, Bladder Cancer, Urothelial Carcinoma, Advanced Non-Small Cell Lung Cancer
Pfizer
Phase 1
540
Changsha
2025-08-20
Not yet open
Efficacy and Safety Analysis of First-Line ABCP Therapy in Advanced SMARCA4-Mutated NSCLC
NCT07093762Non Small Cell Lung Cancer
Fuzhou General Hospital
Observational
35
Fuzhou
2025-08-20
Recruiting
Cryoablation Combined With Lenvatinib Plus QL1706 (Iparomlimab/Tuvonralimab) in Patients With Advanced Intrahepatic Cholangiocarcinoma
NCT07070700Intrahepatic Cholangiocarcinoma (Icc)
Fudan University
Phase 2
56
Shanghai
2025-08-20
Not yet open
Effect of Early Lifestyle Intervention on Perinatal Outcomes in High-risk Women for Gestational Hyperglycemia
NCT07141173GDM
Tianjin Central Hospital of Gynecology Obstetrics
Not applicable
604
Tianjin
2025-08-20
Not yet open
Clinical Observation and Risk Factor Analysis of the Incidence of Postoperative PTSD in Children
NCT07088692PTSD
JianHao Zhang
Observational
400
Beijing
2025-08-20
Not yet open
EBV Lytic Reactivation Therapy Combined With PD-1 Antibody in Recurrent/Metastatic Nasopharyngeal Carcinoma
NCT07138989Nasopharyngeal Cancinoma (NPC)
Sun Yat-sen University
Phase 2
10
Guangzhou
2025-08-19
Recruiting
The Efficacy and Safety of Combined Teriflunomide and High-dose Dexamethasone in Newly Diagnosed Primary Immune Thrombocytopenia (TEMPO-2)
NCT07065968Immune Thrombocytopenia (ITP)
Peking University People's Hospital
Phase 2
132
Beijing
2025-08-19
Recruiting
Study of CM512 Injection in Subjects With Moderate-to-severe Asthma
NCT07011524Asthma
Keymed Biosciences Co.Ltd
Phase 2
200
Guangzhou
2025-08-19
Recruiting
PM8002 (BNT327) in Combination With Chemotherapy in Patients With Metastatic Colorectal Cancer
NCT07133750CRC (Colorectal Cancer)
Biotheus Inc.
Phase 2
100
Beijing, Guangzhou, Harbin, Wuhan, Changchun, Jinan, Shanghai, Chengdu
2025-08-19
Recruiting
A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
NCT07005154Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer, Metastatic Hormone Sensitive Prostate Cancer
Astellas Pharma Global Development, Inc.
Phase 2
218
Yangzhou, Tianjin, Hangzhou, Huaian, Shanghai
2025-08-19
Recruiting
Phase Ib Study of HS-20093+HRS-5041 in Patients With Advanced Prostate Cancer
NCT07115446Advanced Prostate Cancer
Hansoh BioMedical R&D Company
Phase 1
63
Shanghai
2025-08-19
Active, closed
Clinical Trial of the Safety and Efficacy of IBA Proton Therapy System PROTEUSยฎ PLUS (Sichuan)
NCT07152353Solid Tumor, Adult
Ion Beam Applications
Not applicable
47
Chengdu
2025-08-19
Recruiting
DZD8586 Combination Therapy in Patients With Diffuse Large B-cell Lymphoma (TAI-SHAN12)
NCT07059650Diffuse Large B-Cell Lymphoma
Dizal Pharmaceuticals
Phase 1/2
150
Beijing, Changsha, Chengdu, Guangzhou, Hangzhou, Hefei, Linyi, Taiyuan
2025-08-19
Recruiting
Efficacy of Glycemic Improvement Project (GLITTER Study) in Type 1 Diabetes-GLITTER Study 2
NCT07097818Type 1 Diabetes
Second Xiangya Hospital of Central South University
Not applicable
400
Beijing, Quanzhou, Shenzhen, Tangshan, Luoyang, Wuhan, Changsha, Shenyang
2025-08-18
Recruiting
Efficacy and Safety of Trastuzumab Rezetecan Followed by CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2-Low/Ultra-Low Advanced Breast Cancer
NCT07037199Advanced Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 2
45
Guangzhou
2025-08-18
Recruiting
A Randomized, Double-blind, Placebo-controlled, Single and Multiple Dose Escalation Phase I Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of IMC-003 for Injection in Healthy Postmenopausal Women
NCT07118085Healthy Postmenopausal Women
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
Phase 1
56
Chengdu
2025-08-18
Recruiting
Comparing the Components of Composite Endpoints for Healthcare Providers and Patients
NCT07378137Coronary Artery Disease, Percutaneous Coronary Intervention
Xijing Hospital
Observational
600
Xi'an
2025-08-18
Not yet open
XH001 (New Antigen Tumor Vaccine) Combined With Chemotherapy as Adjuvant Therapy in Pancreatic Cancer
NCT07114666Pancreatic Cancer
Peking Union Medical College Hospital
Not applicable
12
Beijing
2025-08-18
Recruiting
Study on the Preferences for PCI Implantation Devices Among Doctors and Patients
NCT07378163Coronary Artery Disease, Percutaneous Coronary Intervention
Xijing Hospital
Observational
600
Xi'an
2025-08-18
Recruiting
A Study to Assess the Efficacy of WSD0922-FU in Patients With C797S+ Advanced Non-small Cell Lung Cancer
NCT06868485Non Small Cell Lung Cancer
Wayshine Biopharm, Inc.
Phase 2
40
Fuzhou, Wuhan, Shanghai, Tianjin
2025-08-18
Recruiting
Safety, Tolerability, and PK/PD of CIGB-814 in Chinese Health Participants
NCT07182656Rheumatoid Arthritis (RA)
Yi Fang
Phase 1
70
Beijing
2025-08-18
Recruiting
Pre-trial of Clinical Trial of Traditional Chinese Medicine Treatment for Elderly Patients With Coronary Heart Disease Who Are Still Symptomatic After Optimal Medical Treatment
NCT07041359Coronary Arterial Disease (CAD)
China National Center for Cardiovascular Diseases
Phase 4
120
Beijing
2025-08-18
Recruiting
To Observe the CD7-targeted CAR-T Therapy in the Treatment of r/r PTCL
NCT07143929CD7 Positive R/R PTCL
Peking University People's Hospital
Phase 1
18
Beijing
2025-08-18
Recruiting
A Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Oral Rilzabrutinib Compared With Placebo in Participants 18 Years of Age and Older With Warm Autoimmune Hemolytic Anemia
NCT07086976Autoimmune Haemolytic Anaemia
Sanofi
Phase 3
90
Beijing, Chengde, Guangzhou, Hohhot, Nanchang, Suzhou, Tianjin, Wuhan
2025-08-18
Recruiting
A Phase III Study of SHR-A1811 in Combination With Chemotherapy and Adebrelimab in Previously Untreated Patients With Gastric or Gastroesophageal Junction Adenocarcinoma
NCT07118527Patients With Unresectable Locally Advanced or Metastatic Untreated Gastric or Gastroesophageal Junction Adenocarcinoma
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 3
600
Shenyang, Shanghai
2025-08-18
Recruiting
EUS-PPG Alteration After Ligation and Sclerotherapy in Esophageal Varices
NCT07253090Esophagogastric Varices
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
70
Hangzhou
2025-08-18
Active, closed
A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)
NCT07005128Small-cell Lung Cancer, Extensive Stage Small-cell Lung Cancer
Amgen
Phase 3
350
Beijing, Quanzhou, Harbin, Jiamusi, Zhengzhou, Nanchang, Jinan, Shanghai
2025-08-18
Recruiting
A Study to Evaluate the Efficacy and Safety of HTMC0658 Tablets in the Treatment of Chronic Rhinosinusitis Without Nasal Polyps
NCT07174115Chronic Sinusitis Without Nasal Polyps
Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.
Phase 2
30
Luoyang
2025-08-18
Recruiting
To Observe the CD7-targeted CAR-T Therapy in the Treatment of MRD Positive T-ALL/LBL Post Allo-HSCT
NCT07280494CD7+ T-ALL/LBL
Peking University People's Hospital
Phase 1
18
Beijing
2025-08-18
By invitation
Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Recombinant Human Anti-Tetanus Toxin Monoclonal Antibody Injection
NCT07149454Tetanus
Lanzhou Institute of Biological Products Co., Ltd
Phase 1
68
Lanzhou
2025-08-18
Recruiting
The Possible Range of No.4sb Lymph Node Dissection of Locally Advanced Distal Gastric Cancer
NCT07183150Gastric Cancer (GC), No.4sb
Tianjin Medical University Cancer Institute and Hospital
Observational
400
Tianjin
2025-08-18
Recruiting
The Efficacy of Temporal Interference Stimulation in the Treatment of Obsessive-Compulsive Disorder
NCT07113652Obsessive-Compulsive Disorder (OCD)
Shanghai Mental Health Center
Not applicable
18
Shanghai
2025-08-17
Recruiting
A Clinical Trial of SIBP-A16 Injection in Healthy Adults
NCT07106918Respiratory Syncytial Virus (RSV)
Shanghai Institute Of Biological Products
Phase EARLY_PHASE1
140
Wuhan
2025-08-17
Active, closed
JS203 Combination Regimens in B-Cell Non-Hodgkin's Lymphoma
NCT07081022B-cell Non-Hodgkin's Lymphoma
Shanghai Junshi Bioscience Co., Ltd.
Phase 2
180
Beijing
2025-08-17
Recruiting
SEEG-Guided DBS for Schizophrenia
NCT07671261Schizophrenia Disorders, Schizo Affective Disorder
Ruijin Hospital
Not applicable
46
Shanghai
2025-08-17
Recruiting
Effect of Handgrip Strength on Portal Vein Hemodynamics in Patients With Liver Cirrhosis
NCT07116096Liver Cirrhosis, Portal Hypertension
Shanxi Provincial People's Hospital
Not applicable
120
Luoyang, Taiyuan
2025-08-17
Recruiting
Anti CD19/BCMA CAR Gene Therapy for Relapsed/Refractory Immune Thrombocytopenia
NCT06973356Immune Thrombocytopenia (ITP)
Anhui Provincial Hospital
Not applicable
18
Changsha
2025-08-16
Not yet open
Chinese Ostomy Collaboration Group (COCG) Clinical Study -SITI Classification
NCT07111429Complication,Postoperative, Stoma
Peking University Cancer Hospital & Institute
Observational
5,000
Beijing
2025-08-15
Recruiting
RN1201 Injection for Autoimmune Diseases Refractory to Standard Therapies
NCT07105735Autoimmune Diseases Refractory to Standard Therapies
The First Affiliated Hospital with Nanjing Medical University
Phase 1
18
Nanjing
2025-08-15
Recruiting
Multi-omics Studies of Primary Aldosteronism
NCT07111351Primary Aldosteronism
Peking University First Hospital
Observational
400
Beijing
2025-08-15
Recruiting
Clinical Study of XNW5004 Combined With CHOP/CHOEP in the Treatment of Untreated Peripheral T-Cell Lymphoma
NCT07730515Non-hodgkin Lymphoma, Peripheral T-cell Lymphoma
Evopoint Biosciences Inc.
Phase 1/2
176
Shanghai
2025-08-15
Recruiting
Clinical Study on Immunogenicity and Safety of Lyophilized Vero Cell-Derived Human Rabies Vaccine in Special Populations
NCT07120464Rabies Exposure, Immunocompromised, Chronic Disease
Liaoning Chengda Biotechnology CO., LTD
Observational
180
Shenzhen
2025-08-15
Not yet open
Effects of Pulsed Electromagnetic Field Therapy on Meniscal Healing, Symptom Relief, and Knee Function
NCT07117929Meniscal Tears
Chinese University of Hong Kong
Not applicable
40
2025-08-15
Recruiting
A Study of IL4Rฮฑ Monoclonal Antibody in Patients With Seasonal Allergic Rhinitis
NCT07154342Allergic Rhinitis, Seasonal
Genrix (Shanghai) Biopharmaceutical Co., Ltd.
Phase 3
150
Wuhan
2025-08-15
Recruiting
Research on Identifying Critical Surgical Anatomy in Cholecystectomy Videos Based on Deep Learning
NCT07158372Cholecystectomy, Surgical Video Identification
Chinese Academy of Sciences
Observational
200
Zhengzhou, Beijing, Shanghai
2025-08-15
By invitation
A Multicenter, Open-label Study Evaluating the Long-term Safety and Efficacy of XH-S003 Capsules in Patients With Paroxysmal Nocturnal Hemoglobinuria
NCT07657052Paroxysmal Nocturnal Hemoglobinuria
S-INFINITY Pharmaceuticals Co., Ltd
Not applicable
26
Tianjin
2025-08-15
Recruiting
HAIC Combined With Camrelizumab Plus Rivoceranib for Advanced Mixed Hepatocellular-cholangiocarcinoma (HCC-CCA)
NCT07105748Mixed Hepatocellular-cholangiocarcinoma
Fudan University
Phase 2
45
Shanghai
2025-08-15
Rows per page Showing 6501–6600 of 19052
Previous 64 65 66 67 68 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site. Derived from ClinicalTrials.gov. Retrieved 23 September 2026. https://priyalifescience.com/clinical-trials-china?page=66

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →
→

Browse trials by condition

Breast Cancer (416) Advanced Solid Tumors (183) Gastric Cancer (183) Colorectal Cancer (179) Hepatocellular Carcinoma (161) Advanced Solid Tumor (159) Solid Tumor (145) Non-Small Cell Lung Cancer (144) Acute Ischemic Stroke (138) Lung Cancer (134) Pancreatic Cancer (132) Non-small Cell Lung Cancer (131) Multiple Myeloma (126) Coronary Artery Disease (111) Prostate Cancer (111)
→

Browse trials by site location

Beijing (5484) Shanghai (3827) Guangzhou (3318) Hangzhou (1812) Wuhan (1343) Chengdu (1291) Nanjing (1193) Changsha (1154) Chongqing (1056) Fuzhou (1018) Tianjin (940) Zhengzhou (921) Hefei (875) Jinan (785) Changchun (641)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.